DVT: a new era in anticoagulant therapy.
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 USA. nmackman@med.unc.edu
Nigel
N
Mackman
Richard C
RC
Becker
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use; D000069604:Dabigatran; D004195:Disease Models, Animal; D065427:Factor Xa Inhibitors; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009025:Morpholines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use; D013917:Thrombin / Q000037:antagonists & inhibitors; D020246:Venous Thrombosis / Q000188:drug therapy*
D000925:Anticoagulants; D001562:Benzimidazoles; D065427:Factor Xa Inhibitors; D009025:Morpholines; D011725:Pyridines; D013876:Thiophenes; D000069552:Rivaroxaban; D013917:Thrombin; D000069604:Dabigatran